Hinge Health Statistics
Total Valuation
Hinge Health has a market cap or net worth of $2.96 billion. The enterprise value is $2.48 billion.
Important Dates
The next confirmed earnings date is Tuesday, February 10, 2026, after market close.
| Earnings Date | Feb 10, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Hinge Health has 78.72 million shares outstanding. The number of shares has increased by 192.34% in one year.
| Current Share Class | 37.92M |
| Shares Outstanding | 78.72M |
| Shares Change (YoY) | +192.34% |
| Shares Change (QoQ) | +79.50% |
| Owned by Insiders (%) | 24.96% |
| Owned by Institutions (%) | 44.16% |
| Float | 31.94M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 24.50 |
| PS Ratio | 2.68 |
| Forward PS | 4.34 |
| PB Ratio | 14.25 |
| P/TBV Ratio | 21.00 |
| P/FCF Ratio | 20.38 |
| P/OCF Ratio | 20.32 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 4.64 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 17.04 |
Financial Position
The company has a current ratio of 1.85, with a Debt / Equity ratio of 0.02.
| Current Ratio | 1.85 |
| Quick Ratio | 1.59 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | n/a |
| Debt / FCF | 0.06 |
| Interest Coverage | n/a |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | -132.27% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | $352,966 |
| Profits Per Employee | -$283,399 |
| Employee Count | 1,514 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -75,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 46.28 |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 25.20 |
| Average Volume (20 Days) | 827,049 |
Short Selling Information
The latest short interest is 861,980, so 1.10% of the outstanding shares have been sold short.
| Short Interest | 861,980 |
| Short Previous Month | n/a |
| Short % of Shares Out | 1.10% |
| Short % of Float | 2.70% |
| Short Ratio (days to cover) | 0.83 |
Income Statement
In the last 12 months, Hinge Health had revenue of $534.39 million and -$429.07 million in losses. Loss per share was -$11.28.
| Revenue | 534.39M |
| Gross Profit | 421.22M |
| Operating Income | -545.93M |
| Pretax Income | -533.32M |
| Net Income | -429.07M |
| EBITDA | -543.75M |
| EBIT | -545.93M |
| Loss Per Share | -$11.28 |
Full Income StatementBalance Sheet
The company has $480.03 million in cash and $9.03 million in debt, with a net cash position of $486.07 million or $6.17 per share.
| Cash & Cash Equivalents | 480.03M |
| Total Debt | 9.03M |
| Net Cash | 486.07M |
| Net Cash Per Share | $6.17 |
| Equity (Book Value) | 407.87M |
| Book Value Per Share | 2.64 |
| Working Capital | 301.81M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $145.89 million and capital expenditures -$457,000, giving a free cash flow of $145.43 million.
| Operating Cash Flow | 145.89M |
| Capital Expenditures | -457,000 |
| Free Cash Flow | 145.43M |
| FCF Per Share | $1.85 |
Full Cash Flow StatementMargins
Gross margin is 78.82%, with operating and profit margins of -102.16% and -99.78%.
| Gross Margin | 78.82% |
| Operating Margin | -102.16% |
| Pretax Margin | -99.80% |
| Profit Margin | -99.78% |
| EBITDA Margin | -101.75% |
| EBIT Margin | -102.16% |
| FCF Margin | 27.21% |
Dividends & Yields
Hinge Health does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -192.34% |
| Shareholder Yield | -192.34% |
| Earnings Yield | -14.48% |
| FCF Yield | 4.91% |
Analyst Forecast
The average price target for Hinge Health is $60.13, which is 59.71% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $60.13 |
| Price Target Difference | 59.71% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 17 |
| Revenue Growth Forecast (5Y) | 23.09% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Hinge Health has an Altman Z-Score of 3.19 and a Piotroski F-Score of 3.
| Altman Z-Score | 3.19 |
| Piotroski F-Score | 3 |
